Alfred Chu
Cardiovascular Disease · Amarillo, TXNPI 1922181916
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,351 of the $5,538 with a category attached, or 60.5%. 12 manufacturers reported payments, led by Abiomed at 48.0% of the total. Reporting peaked in 2019 at $2,899 and has fallen 99.3% since, to $20 in 2023.
Across 74 payments — averaging $74.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abiomed$3K
- Abbott$1K
- Cordis US CORP.$1K
- Amarin Pharma, Inc.$202
- Medtronic$119
- Boston Scientific$82
- plus $96 from 6 others
Across 242 payments — averaging $5208.68 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- CSL Behring$1.1M
- American Regent$100K
- Esperion Therapeutics, Inc.$34K
- Boehringer Ingelheim Pharma GmbH & Co.kg$26K
- Boehringer Ingelheim International GmbH$23K
- Vifor (international) Ltd.$6K
- plus $5K from 2 others
What the payments were for
- Consulting fees$1,00018%
- Travel & lodging$1,18721%
- Food & beverage$3,35161%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abiomed | 15 | $2,658 |
| Abbott | 46 | $1,365 |
| Cordis US CORP. | 2 | $1,017 |
| Amarin Pharma, Inc. | 2 | $202 |
| Medtronic(2 entities) | 2 | $119 |
| Boston Scientific | 1 | $82 |
| E.r. Squibb & Sons, L.L.C. | 1 | $20 |
| Cardinal Health 200 LLC | 1 | $20 |
| Amgen | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Esperion Therapeutics, Inc. | 1 | $11 |
| Cardiovascular Systems Inc. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,538 in reported general payments places this provider in the 60th percentile of 1,515 cardiovascular disease providers in Texas.
Other cardiovascular disease in Amarillo
- David BrabhamAmarillo$121K
- Ramin Farzaneh-FarDallas$17.1M
- John OsborneGrapevine$1.3M
- Darren McGuireDallas$1.2M
- Peter McCulloughDallas$664K
- Ann NavarDallas$616K
- Biykem BozkurtHouston$606K
- Milton PackerDallas$530K
- Amarinder BindraDallas$512K
- Robert SalazarKingwood$478K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.